Wealthspire Advisors (Maryland)’s Eagle Pharmaceuticals, Inc. EGRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q2 | – | Sell |
-40
| Closed | -$2K | – | 2198 |
|
|
2019
Q1 | $2K | Buy |
40
+6
| +18% | +$300 | ﹤0.01% | 2227 |
|
|
2018
Q4 | $1K | Buy |
+34
| New | +$1K | ﹤0.01% | 2356 |
|
|
2018
Q1 | – | Sell |
-16
| Closed | -$1K | – | 2674 |
|
|
2017
Q4 | $1K | Buy |
16
+14
| +700% | +$875 | ﹤0.01% | 2364 |
|
|
2017
Q3 | $0 | Buy |
+2
| New | – | ﹤0.01% | 2511 |
|
|
2016
Q1 | – | Sell |
-15
| Closed | -$1K | – | 1872 |
|
|
2015
Q4 | $1K | Buy |
+15
| New | +$1K | ﹤0.01% | 1667 |
|